DK0509042T3 - Intravenøst administrerbart farmaceutisk præparat af 1-octadecyl-2-methyl-glycero-3-phosphocholin - Google Patents

Intravenøst administrerbart farmaceutisk præparat af 1-octadecyl-2-methyl-glycero-3-phosphocholin

Info

Publication number
DK0509042T3
DK0509042T3 DK91902674.0T DK91902674T DK0509042T3 DK 0509042 T3 DK0509042 T3 DK 0509042T3 DK 91902674 T DK91902674 T DK 91902674T DK 0509042 T3 DK0509042 T3 DK 0509042T3
Authority
DK
Denmark
Prior art keywords
lipophilic
pharmaceutical preparation
och3
emulsion
active substance
Prior art date
Application number
DK91902674.0T
Other languages
English (en)
Inventor
Rabbe Nordstroem
Dieter Wiebecke
Original Assignee
Medmark Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmark Pharma Gmbh filed Critical Medmark Pharma Gmbh
Application granted granted Critical
Publication of DK0509042T3 publication Critical patent/DK0509042T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91902674.0T 1990-01-03 1990-12-21 Intravenøst administrerbart farmaceutisk præparat af 1-octadecyl-2-methyl-glycero-3-phosphocholin DK0509042T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4000084A DE4000084A1 (de) 1990-01-03 1990-01-03 Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts)

Publications (1)

Publication Number Publication Date
DK0509042T3 true DK0509042T3 (da) 1994-05-09

Family

ID=6397585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902674.0T DK0509042T3 (da) 1990-01-03 1990-12-21 Intravenøst administrerbart farmaceutisk præparat af 1-octadecyl-2-methyl-glycero-3-phosphocholin

Country Status (7)

Country Link
EP (1) EP0509042B1 (da)
JP (1) JPH05502878A (da)
AT (1) ATE102023T1 (da)
DE (2) DE4000084A1 (da)
DK (1) DK0509042T3 (da)
ES (1) ES2062763T3 (da)
WO (1) WO1991009590A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009769A1 (en) * 1992-11-02 1994-05-11 Buchman Alan L Use of choline in total parenteral nutrition
WO1997004765A1 (en) * 1995-07-25 1997-02-13 Smithkline Beecham Corporation INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
DE19822509A1 (de) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin zur Behandlung von Hirntumoren
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
EP2091520B1 (en) 2006-11-10 2012-02-22 Alphaptose Gmbh Oral dosage form comprising tri-substituted glycerol compounds
US8637688B2 (en) * 2006-12-20 2014-01-28 Julia Diederichs Topical dosage form comprising tri-substituted glycerol compounds
ES2396718T3 (es) 2006-12-20 2013-02-25 Alphaptose Gmbh Uso de compuestos de glicerol tri-sustituidos para el tratamiento de neoplasias malignas

Also Published As

Publication number Publication date
EP0509042B1 (de) 1994-03-02
JPH05502878A (ja) 1993-05-20
ATE102023T1 (de) 1994-03-15
ES2062763T3 (es) 1994-12-16
DE4000084A1 (de) 1991-07-04
DE59004838D1 (de) 1994-04-07
WO1991009590A1 (de) 1991-07-11
EP0509042A1 (de) 1992-10-21

Similar Documents

Publication Publication Date Title
DE3686797D1 (de) Emulsionen zur verabreichung in wasser schwerloeslicher ionisierbarer basischer hydrophober arzneistoffe.
Robinson et al. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2
Koerber et al. Coexistent psoriasis and bullous pemphigoid: a report of six cases
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
Valentic et al. Hypercalcemia associated with oral isotretinoin in the treatment of severe acne
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
DK0509042T3 (da) Intravenøst administrerbart farmaceutisk præparat af 1-octadecyl-2-methyl-glycero-3-phosphocholin
SE7711102L (sv) Nya medel och nya sett att behandla klimakteriska bortfallsymptom
Trainin et al. Late nonresponsiveness to steroids in children with the nephrotic syndrome
JPH06279276A (ja) 免疫不全症候群治療の補助療法剤
DE3883208D1 (de) Mittel zur behandlung von keratose.
Acocella et al. Serum and urine concentrations of rifampicin administered by intravenous infusion in man
Bollet Piroxicam serum levels in patients treated for rheumatic diseases
DE69530779T2 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation
Robertson et al. Toxicity of doxorubicin and methotrexate in osteogenic sarcoma.
JPH0251405B2 (da)
US3429971A (en) Method of treating avian lymphomatosis induced by es4 strain of lymphomatosis virus
RU2218166C2 (ru) Способ лечения демиелинизирующих заболеваний
Shnider Early human trials with anticancer agents: Dosage schedules and routes of administration
KORBERLY et al. Ethotoin use in pediatric seizure patients
Merimsky et al. Interferon-related leukoencephalopathy in a patient with renal cell carcinoma
Stone et al. A note on the uselessness of analeptic drugs combined with Luminal in the treatment of epilepsy
Kushner Experience with greater than recommended doses of fluphenazine and triflupromazine
Sakurai et al. Liposteroid therapy for chronic childhood idiopathic thrombocytopenic purpura: Two case reports